FREE Account Opening + No Clearing Fees
Loading...

Basilic Fly Studio IPO vs Mono Pharmacare IPO

Comparision between Basilic Fly Studio IPO and Mono Pharmacare IPO.

IPO Details

Basilic Fly Studio IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Mono Pharmacare IPO is a SME Book Built Issue proposed to list at NSE SME.

  Basilic Fly Studio IPO Mono Pharmacare IPO
Logo Basilic Fly Studio IPO Logo Mono Pharmacare IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At NSE SME NSE SME
Lead Managers GYR Capital Advisors Private Limited Unistone Capital Pvt Ltd
Registrar Purva Sharegistry India Pvt Ltd Bigshare Services Pvt Ltd
Market Maker Share India Securities Limited Rikhav Securities Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Basilic Fly Studio IPO is up to ₹66.35 Cr whereas the issue size of the Mono Pharmacare IPO is up to ₹14.84 Cr. The final issue price of Basilic Fly Studio IPO is ₹97.00 per share and of Mono Pharmacare IPO is ₹28.00 per share.

  Basilic Fly Studio IPO Mono Pharmacare IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹92.00 per share ₹26.00 per share
Issue Price (Upper) ₹97.00 per share ₹28.00 per share
Issue Price (Final) ₹97.00 per share ₹28.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 1200 shares 4000 shares
Fresh Issue Size 62,40,000 shares 53,00,000 shares
Fresh Issue Size (Amount) up to ₹60.53 Cr up to ₹14.84 Cr
OFS Issue Size 6,00,000 shares
OFS Issue Size (Amount) up to ₹5.82 Cr
Issue Size Total 68,40,000 shares 53,00,000 shares
Issue Size Total (Amount) up to ₹66.35 Cr up to ₹14.84 Cr

IPO Timetable

Basilic Fly Studio IPO opens on Sep 01, 2023, while Mono Pharmacare IPO opens on Aug 28, 2023. The closing date of Basilic Fly Studio IPO and Mono Pharmacare IPO is Sep 05, 2023, and Aug 30, 2023, respectively.

  Basilic Fly Studio IPO Mono Pharmacare IPO
Anchor Bid Date Aug 31, 2023
Issue Open Sep 01, 2023 Aug 28, 2023
Issue Close Sep 05, 2023 Aug 30, 2023
Basis Of Allotment (Tentative) Sep 11, 2023 Sep 04, 2023
Initiation of Refunds (Tentative) Sep 12, 2023 Sep 05, 2023
Credit of Share (Tentative) Sep 13, 2023 Sep 06, 2023
Listing date (Tentative) Sep 14, 2023 Sep 07, 2023
Anchor Lockin End date 1 Oct 11, 2023 Oct 04, 2023
Anchor Lockin End date 2 Dec 10, 2023 Dec 03, 2023

Financials

Basilic Fly Studio IPO P/E ratio is 5.94, as compared to Mono Pharmacare IPO P/E ratio of .

  Basilic Fly Studio IPO Mono Pharmacare IPO
Financial
Basilic Fly Studio IPO Financial Information (Restated Consolidated)
Period Ended31 Mar 202231 Mar 2023
Assets1,571.085,315.33
Revenue2,528.787,895.15
Profit After Tax90.102,774.02
Net Worth394.163,166.98
Reserves and Surplus274.171,466.98
Total Borrowing413.23427.08
Amount in ₹ Lakhs
Mono Pharmacare IPO Financial Information (Restated Consolidated)
Period Ended31 Mar 202031 Mar 202131 Mar 202231 Mar 2023
Assets871.701,122.461,438.316,257.39
Revenue1,168.902,837.833,710.27
Profit After Tax1.999.5135.09
Net Worth201.92369.58427.57
Reserves and Surplus131.71
Total Borrowing633.46608.03643.93
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 85.42% 81.02%
Promoter Shareholding (Post-Issue)
P/E Ratio 5.94
Market Cap ₹225.43 Cr. ₹49.47 Cr.
ROE 155.63%% 9.01%%
ROCE 104.73%% 10.34%%
Debt/Equity 0.14 2.92
EPS ₹16.32 ₹1.99
RoNW 87.59%% 9.01%%

Shares Offered

In the Basilic Fly Studio IPO retail investors (RII) are offered 20,35,200 shares while in Mono Pharmacare IPO retail investors are offered 20,35,200 shares. Qualified institutional buyers (QIB) are offered 11,62,800 shares in Basilic Fly Studio IPO and 5,00,000 shares in Mono Pharmacare IPO.

  Basilic Fly Studio IPO Mono Pharmacare IPO
Anchor Investor Reserveration 17,43,600 shares
Market Maker Reserveration 10,26,000 shares 2,76,000 shares
QIB 11,62,800 shares 5,00,000 shares
NII 8,72,400 shares 22,60,000 shares
RII 20,35,200 shares 22,64,000 shares
Employee 0 shares 0 shares
Others
Total 40,70,400 shares 50,24,000 shares

Bids Received (Subscription)

Basilic Fly Studio IPO subscribed 358.60x in total, whereas Mono Pharmacare IPO subscribed 13.42x.

  Basilic Fly Studio IPO Mono Pharmacare IPO
QIB (times) 116.34x 10.89x
NII (times) 549.44x 8.00x
Big NII (times)
Small NII (times)
RII (times) 415.22x 19.40x
Employee (times)
Other (times)
Total (times) 358.60x 13.42x

Comments

Add a public comment...